Dose Escalation Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Epelsiban Administered in Repeat Doses in Healthy Women Volunteers
Clinical trial NCT02703181 · COMPLETED
Trial details
- NCT number
- NCT02703181
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-09
- Primary completion
- 2015-09-10
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.